India markets closed

  • BSE SENSEX

    48,080.67
    +374.87 (+0.79%)
     

  • Nifty 50

    14,406.15
    +109.75 (+0.77%)
     

  • Dow

    34,137.31
    +316.01 (+0.93%)
     

  • Nasdaq

    13,950.22
    +163.95 (+1.19%)
     

  • BTC-INR

    4,134,680.75
    +3,395.25 (+0.08%)
     

  • CMC Crypto 200

    1,282.71
    +19.75 (+1.56%)
     

  • Hang Seng

    28,755.34
    +133.42 (+0.47%)
     

  • Nikkei

    29,188.17
    +679.62 (+2.38%)
     

  • EUR/INR

    90.3662
    -0.4306 (-0.47%)
     

  • GBP/INR

    104.1081
    -0.9556 (-0.91%)
     

  • AED/INR

    20.3560
    -0.1330 (-0.65%)
     

  • INR/JPY

    1.4379
    +0.0081 (+0.57%)
     

  • SGD/INR

    56.4930
    -0.2810 (-0.49%)
     
DOWNLOAD:

The best finance destination to track markets & economy

Tesla targets India, but faces bumpy road

Right now China is one of Tesla's most important markets, accounting for about 30% of its sales.

But the electric car pioneer has its sights set on another Asian giant.

Tesla is now targeting India.

Sources have told Reuters the firm is seeking sites for showrooms in New Delhi, Mumbai and Bengaluru.

It's also hired a prominent local executive to lead its policy and business development efforts in the country.

Back in October company founder Elon Musk said Tesla would enter India in 2021 'for sure'.

The search for showroom space suggests that effort is accelerating.

But the country looks like a tough nut for Tesla to crack.

The country has negligible infrastructure for charging electric vehicles.

It also imposes high taxes on imported cars.

Last year it recorded just 5,000 EV sales, out of a total 2.4 million cars sold.

China, by contrast, saw sales of new energy vehicles touch 1.25 million.

Even so, analysts say India's growing number of affluent consumers make it a market the automaker can't ignore.

The country's roads minister has also said India could offer incentives to tempt Tesla into making its cars there.

Latest stories

  • PBKS vs MI Dream11 Prediction, Fantasy Cricket Tips, Playing XI, Pitch Report, Dream11 Team, Injury Update – VIVO IPL 2021

    Punjab Kings (PBKS) vs Mumbai Indians (MI) MI Dream11 Prediction, Fantasy Cricket Tips, Playing XI, Fantasy Team, Pitch Report, Dream11 Team, Injury Update of VIVO IPL 2021. Both the teams are coming off a defeat in their previous games and will be desperate to get back to winning ways. PBKS vs MI VIVO IPL 2021 Match 17 Details: The seventeenth match of VIVO IPL 2021 will be played on the 23rd of April at M.A. Chidambaram Stadium (Chepauk), Chennai between Punjab Kings (PBKS) and Mumbai Indians (MI). The game is scheduled to start at 07:30 PM IST and the live The post PBKS vs MI Dream11 Prediction, Fantasy Cricket Tips, Playing XI, Pitch Report, Dream11 Team, Injury Update – VIVO IPL 2021 appeared first on CricketAddictor.

  • Earth day 2021: Climate scientists caution concept of net zero is a dangerous trap

    If we deploy CO2 removal techniques and reduce fossil fuel burning, it is believed that we can halt global warming.

  • Rare-Earth Metals (Lanthanum, Cerium, Neodymium, Praseodymium, Samarium, Europium, Others) Market - Global Forecast to 2026 - ResearchAndMarkets.com

    The "Global Rare-Earth Metals Market by Type (Lanthanum, Cerium, Neodymium, Praseodymium, Samarium, Europium, Others), Application (Permanent Magnets, Metals Alloys, Polishing, Additives, Catalysts, Phosphors), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

  • Madras HC recruitment 2021: Applications open for 3,557 posts, check jrchcm.onlineregistrationform.org

    The last date to apply is 6 June. The HC will conduct a written exam of 50 objective multiple choice questions, each carrying 1 mark

  • The Center for Workforce Health and Performance and National Association of Worksite Health Centers Release Report to Help Employers and Insurers Manage Musculoskeletal Conditions

    OAKLAND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Disability leaves for musculoskeletal conditions such as back pain and arthritis are estimated to cost insurers and employers about $6.3 billion annually. To offer employers insights to help employees manage these pain conditions, The Center for Workplace Health and Performance (CWHP) and National Association of Worksite Health Centers (NAWHC) released a report around the science and practice of a patient-centered approach to managing musculoskeletal disorders. As part of these efforts, CWHP and NAWHC examined recent studies of patients with pain and hosted a virtual symposium on managing pain and musculoskeletal conditions in worksite health settings. The project was funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (EAIN-00102). “What’s important about this report is that it starts with two types of evidence in managing pain and musculoskeletal conditions: high-quality comparative effectiveness trials, and the experiences of worksite health practitioners,” said CWHP president Brian Gifford. “Both approaches ended up drawing our attention to patients as a third source of expertise. Employers that can encourage provider teams to include employees’ wants and expectations about their own care stand to benefit from their improved well-being and ability to contribute fully on the job.” The report includes a summary of PCORI studies, a recap of the session discussions, and guidance on how future patient-centered research can close evidence gaps in best practices to guide discussions with occupational health professionals. Particular focus is given to managing and treating pain and integrating providers for improved outcomes. About the National Association of Worksite Health Centers NAWHC is the nation’s only non-profit organization focused on assisting public and private employers and their vendor partners in developing and getting the greatest return from their onsite, near-site, shared and virtual health centers, onsite pharmacies, worksite fitness and wellness centers. nawhc.org About The Center for Workforce Health and PerformanceThe Center for Workforce Health and Performance is an independent and objective source for scientific reports, educational resources, research & evaluation, and technical assistance on healthier, longer and more fulfilling working lives. CWHP contributes to the adoption of evidence-based policies and practices that support healthier, longer and more fulfilling working lives, a healthier economy and, in turn, healthier and more productive communities. tcwhp.org CONTACT: Cary Conway cary@conwaycommunication.com

  • Global Eco-Friendly Bitumen Markets to 2025: Key Players are Royal Dutch Shell, American Gilsonite Company and Kraton Corporation

    Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "Eco-Friendly Bitumen Market - A Global Market and Regional Analysis: Focus on Applications, Products, Grades, Patent Analysis, and Country Analysis - Analysis and Forecast, 2020-2025" report has been added to ResearchAndMarkets.com's offering. Global Eco-Friendly Bitumen Market to Reach $126,743.58 by 2025Eco-friendly bitumen is an emerging market which is projected to follow an upward growth trend primarily driven by growing consumers inclination towards sustainable construction. Eco-friendly bitumen is available in multiple forms in market such as bio-based bitumen, recycled bitumen, and natural bitumen. Recycled bitumen registered the highest demand in global eco-friendly bitumen market owing to increasing awareness regarding road pavements recycling and environmental benefits associate with the same.Major growth driver for global eco-friendly bitumen market is escalating highways and roadways construction activities across the world. several economies have witnessed high growth in transportation infrastructure due to increasing vehicle sales, population, and urbanization. In India, highway construction increased by a CAGR of 21.4% from the year 2016-19 (as per IBEF, November 2020 report) with the construction of 10,855 km of highways. Construction being the major application of eco-friendly bitumen, growing highways contrition is projected to remain the primary factor for uplifting product demand till 2025.Despite of having a positive growth prospect, global eco-friendly bitumen demand faced a major setback in 2020 due to declining construction activities in most parts of the world. due to COVID 19 outbreak, various countries have witnessed a fall in construction activities in 2020 which has negatively impacted the demand of eco-friendly bitumen in the same year. For instance, Europe registered a decline of over 25% in construction activities in the April-May 2020 period. Such huge falls in construction industry has a severe impact on eco-friendly bitumen demand in 2020. however, with the industry regaining its original pace, the eco-friendly bitumen demand is also forecasted to follow a significant growth trend in the near future.Competitive LandscapeThe competitive landscape of the eco-friendly bitumen market comprises of strategies adopted by key players to strengthen their market presence. The global eco-friendly bitumen market has witnessed partnerships, collaboration, joint ventures, new product launches, and some business expansion strategies by various industry players. The market is still in its emerging phase in the market, and the investment in the market is less. However, the market has a high growth potential growth, and therefore, various construction companies are adopting measures to expand their product portfolios in green and sustainable bitumen alternatives. For instance, In July 2020, CEMEX launched an eco-friendly single asphalt solution for cycle lanes and footpaths, which eliminates the need for multi-layering surfaces. The product has achieved a carbon footprint reduction. Such measures are expected to increase awareness regarding sustainable construction materials in the industry while also positively influencing global eco-friendly bitumen market growth.As global construction industry is moving towards sustainable construction materials, companies are increasingly adopting strategies to strengthen their product portfolios in eco-friendly products by practicing mergers, acquisitions, joint ventures, and various such techniques. Key players in the market are Royal Dutch Shell, American Gilsonite Company and Kraton Corporation, among others. Key Questions Answered in this Report: What are the current trends in the global bitumen industry regarding sustainability?How has the global bitumen market been impacted by the introduction of eco-friendly bitumen?What is the growth prospect of bio-based bitumen in road construction?Can the future of the construction industry be bio-based?Which are the major patents filled in the market?What is the role of the government regarding environmental issues and safety that is changing the landscape of the eco-friendly bitumen industry?Which bitumen source is expected to lead the eco-friendly bitumen market by 2025?What was the market value of the leading segments and sub-segments of the market in 2019, and how is the market estimated to grow during the forecast period 2020-2025?How is the industry expected to evolve during the forecast period 2020-2025?What are the key developmental strategies that are implemented by the key players to sustain in the competitive market?What are the key growth regions in the eco-friendly bitumen market?What are the major challenges inhibiting the growth of the eco-friendly bitumen market? Key Topics Covered: 1 Markets1.1 Industry Outlook1.1.1 Industry Dynamics Defining the Future1.1.1.1 Increasing Use of Reclaimed Asphalt in Road Construction1.1.1.2 Innovation in Technology and Research in Bitumen Industry1.1.1.3 Escalating Bitumen Consumption in Cycling Paths1.1.2 Supply Chain Analysis1.1.3 Industry Attractiveness1.1.4 Ecosystem/Ongoing Programs1.1.5 Patent Analysis1.1.5.1 Introduction1.1.5.2 Patent Landscape: Bio-Based Bitumen1.1.5.3 Patent Landscape: Recycled Bitumen1.1.5.4 Patent Landscape: Natural Bitumen1.2 Business Dynamics1.2.1 Business Drivers1.2.1.1 Increasing Demand for Sustainable Roads1.2.1.2 Escalating Global Roadways and Highways Construction Activities1.2.1.3 Stringent Government Regulations for Reducing Carbon Footprints.1.2.1.4 Increasing Demand for Reducing Emissions from Building Sector1.2.2 Business Challenges1.2.2.1 Lack of Awareness among Consumers Coupled with High Cost1.2.3 Business Opportunity1.2.3.1 Rising Inclination toward Alternative Binders in Road Pavements1.2.4 Business Strategies1.2.4.1 Product Development and Innovation1.2.4.2 Market Developments1.2.5 Corporate Strategies1.2.5.1 Partnerships, Collaborations, Mergers and Acquisitions, and Joint Ventures 2 Application2.1 Application and Specification2.1.1 Construction2.1.2 Waterproofing2.1.3 Paints and Coatings2.1.4 Others2.2 Demand Analysis of Eco-Friendly Bitumen (by Application)2.2.1 Construction2.2.2 Waterproofing2.2.3 Paints and Coatings2.2.4 Others 3 Products3.1 Global Eco-Friendly Bitumen Market (by Source)3.1.1 Bio-Based Bitumen3.1.2 Recycled Bitumen3.1.3 Natural Bitumen3.2 Demand Analysis of Eco-Friendly Bitumen (by Source)3.2.1 Bio-Based3.2.2 Recycled Bitumen3.2.3 Natural Bitumen3.3 Global Eco-Friendly Bitumen Market (by Grade)3.3.1 Paving Grade Bitumen3.3.2 Oxidized Bitumen3.3.3 Hard Grade Bitumen3.3.4 Others3.4 Demand Analysis of Eco-Friendly Bitumen Market (by Grade)3.4.1 Paving Grade Bitumen3.4.2 Oxidized Bitumen3.4.3 Hard Grade Bitumen3.4.4 Others 4 Region 5 Competitive Benchmarking & Company Profiles American Gilsonite CompanyAgarwal Industrial Corporation LimitedATDM CO. LTDAvello BioenergyBharat Petroleum Corporation LtdCosmique Pvt. Ltd.Eagle PetrochemGilsonite, CoJalnidhi Bitumen Specialties PVT. Ltd.Mamz Asphalt Technologies (Pvt) Ltd.Nikan West GilsoniteNuroil TradingRoyal Dutch ShellVentracoZista Gilsonite For more information about this report visit https://www.researchandmarkets.com/r/brzx81 CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Cloud Security Alliance Shines Light on Excellence in Cloud Provider Security

    CSA's Trusted Cloud Provider trustmark will assist consumers in identifying cloud providers that demonstrate their commitment to holistic security.

  • Give country solution, not hollow speeches: Rahul Gandhi to govt on COVID-19 situation

    New Delhi, Apr 22 (PTI) The crisis in the country is not just due to coronavirus but also because of anti-people policies of the central government, Congress leader Rahul Gandhi said on Thursday, and called for a solution instead of hollow speeches.

  • German upper house backs new law to fight third COVID wave

    Germany's upper house of parliament approved a law on Thursday to give Chancellor Angela Merkel's government more powers to fight a third wave of the coronavirus. The new law enables the national government to impose curfews between 10 p.m. and 5 a.m., as well as limits on private gatherings, sport and shop openings. The law still needs the signature of President Frank-Walter Steinmeier before it can come into force.

  • Global Pea Starch Market Share, Size, Trends, Industry Analysis Report 2021-2028 - ResearchAndMarkets.com

    The "Pea Starch Market Share, Size, Trends, Industry Analysis Report, By Type; By Application; By End-Use; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

  • Semtech Accelerates Technology Deployments Aimed at a Smarter, Sustainable Planet

    Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, is amplifying its mission to make the planet a smarter, more connected and sustainable place by providing an innovative Internet of Things (IoT) platform. With solutions deployed globally, Semtech’s LoRa® devices and the LoRaWAN® protocol help reduce environmental impacts and remedy challenges facing the global community spanning wildlife protection, sustainable farming, combating COVID-19, water conservation to high-risk flood monitoring.

  • Giyani Announces Bursary to Rhodes University and Appointment of Investor Relations Consultant

    Not for distribution to U.S. newswire services or for dissemination in the United States TORONTO, April 22, 2021 (GLOBE NEWSWIRE) -- Giyani Metals Corp. (TSXV:EMM, GR:A2DUU8) (“Giyani” or the “Company”) is pleased to announce the appointment Red Cloud Financial Services (“Red Cloud”) to provide the Company with range of capital markets advisory and corporate communication services. The Company will also enter into a memorandum of understanding (“MOU”) with the Postgraduate Research in Iron and Manganese Ore Resource (PRIMOR) unit at Rhodes University in South Africa to award a bursary valued at $12,500 per year over the next two years. Red Cloud Appointment Under the engagement, Red Cloud will be paid a fee of $10,000 per month for services commencing May 1, 2021 and for an initial six-month period and the arrangement can automatically renew month-to-month thereafter at the option of the Company. Red Cloud will assist Giyani with all aspects of its marketing strategy and will provide services such as the organizing and administering of road shows, drafting of marketing materials, social and traditional media support and assistance in the creation of video content for exclusive use on Red Cloud TV. Rhodes University Bursary Under the MOU, Giyani will award a bursary to the value of each year $12,500 over two years - 2021 and 2022. This bursary will fund students within the PRIMOR unit at Rhodes University to conduct scientific research in battery-grade manganese ore deposits in Southern Africa. Recipients of the bursary must currently be registered research student(s) at Master’s or PhD level. Preference will be given to students from previously disadvantaged backgrounds from a Southern African country. About Giyani Giyani Metals Corp. is a mineral resource company focused on the development of its K.Hill, Lobatse & Otse manganese oxide projects in the Kanye Basin, Botswana, Africa. The Company’s flagship K.Hill project is a near-surface deposit currently going through a feasibility study to produce high-purity electrolytic manganese metal and manganese sulphate, both key cathode ingredients for batteries in the expanding electric vehicle (EV) market. Additional information and corporate documents may be found on www.sedar.com and on Giyani Metals Corp. Website: https://giyanimetals.com/. About Red Cloud Red Cloud Financial Services is an affiliate of Red Cloud Securities Inc. and is a globally oriented resource focused financial services platform offering clients an extensive array of corporate access services including advisory, marketing and media. Red Cloud Securities Inc. is registered as an Investment Dealer in Ontario, Quebec. Alberta and British Columbia and is a member of the Investment Industry Organization of Canada (IIROC). Part of Red Cloud’s business is to connect mineral exploration and mining companies with suitable investors. For additional information about Red Cloud go to: www.redcloudfs.com About Rhodes University With just over 8,200 students, Rhodes University is a small university located in the Eastern Cape in South Africa. The university has one of the best undergraduate pass and graduation rates in the country, outstanding postgraduate success rates, and the best research output per academic staff member. With 30% of the students being postgraduates, and over 18% international students from 54 countries worldwide, Rhodes University is a dynamic and cosmopolitan knowledge institution. Students can undertake an extensive range of undergraduate and postgraduate degrees in Humanities, Science, Commerce, Pharmacy, Law, and Education. PRIMOR is a research unit established in the Geology Department at Rhodes University in 2013. It is a virtual research entity dedicated to the study of iron and manganese deposits and their origins through the involvement of postgraduate students (MSc, PhD) and postdoctoral fellows. The primary goal of PRIMOR is to provide a hub for world-class research and training of geoscience graduates with a chosen focus on the economic geology of iron and manganese. On behalf of the Board of Directors of Giyani Metals Corp. Robin Birchall, CEO Contact:Robin Birchall CEO, Director+44 7711 313019rbirchall@giyanimetals.com Judith WebsterCorporate Secretary and Investor Relations+1 416 453 8818jwebster@giyanimetals.com Neither the TSX Venture Exchange (the “TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and accordingly, may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. persons,” as such term is defined in Regulation S promulgated under the U.S. Securities Act (“U.S. Persons”), except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the Company’s securities to, or for the account of benefit of, persons in the United States or U.S. Persons. Forward Looking Information This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. All statements in this news release, other than statements of historical fact, that address events or developments that Giyani expects to occur, are “forward-looking statements”. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "does not expect", "plans", "anticipates", "does not anticipate", "believes", "intends", "estimates", "projects", "potential", "scheduled", "forecast", "budget" and similar expressions, or that events or conditions "will", "would", "may", "could", "should" or "might" occur. Specific forward-looking statements and forward-looking information herein includes completion of receipt of TSXV approval for the private placement and completion of the private placement. All such forward-looking statements are based on the opinions and estimates of the relevant management as of the date such statements are made and are subject to certain assumptions, important risk factors and uncertainties, many of which are beyond Giyani’s ability to control or predict. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors that may cause actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. In the case of Giyani, these facts include their anticipated operations in future periods, planned exploration and development of its properties, and plans related to its business and other matters that may occur in the future. This information relates to analyses and other information that is based on expectations of future performance and planned work programs. Forward-looking information is subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking information, including, without limitation: inherent exploration hazards and risks; risks related to exploration and development of natural resource properties; uncertainty in Giyani’s ability to obtain funding; commodity price fluctuations; recent market events and conditions; risks related to the uncertainty of mineral resource calculations and the inclusion of inferred mineral resources in economic estimation; risks related to governmental regulations; risks related to obtaining necessary licenses and permits; risks related to their business being subject to environmental laws and regulations; risks related to their mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to competition from larger companies with greater financial and technical resources; risks relating to the inability to meet financial obligations under agreements to which they are a party; ability to recruit and retain qualified personnel; and risks related to their directors and officers becoming associated with other natural resource companies which may give rise to conflicts of interests. This list is not exhaustive of the factors that may affect Giyani’s forward-looking information. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking information or statements. Giyani’s forward-looking information is based on the reasonable beliefs, expectations and opinions of their respective management on the date the statements are made, and Giyani does not assume any obligation to update forward looking information if circumstances or management’s beliefs, expectations or opinions change, except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking information. For a complete discussion with respect to Giyani and risks associated with forward-looking information and forward-looking statements, please refer to Giyani’s financial statements and related MD&A, all of which are filed on SEDAR at www.sedar.com. GIYANI METALS CORP.www.giyanimetals.com TSXV:EMM

  • Agilent LC/MS Instruments Receive ACT Labels from My Green Lab

    Agilent Technologies Inc. (NYSE: A) announced today that both the InfinityLab LC/MSD iQ and the Ultivo Triple Quadrupole LC/MS systems have earned the highly-respected Accountability, Consistency and Transparency (ACT) Label from My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research.

  • dotdigital Announced as Official Supporter of the Terra Carta as It Accelerates Its Sustainability Commitments

    To mark today’s World Earth Day, leading marketing automation and customer engagement platform, dotdigital, has announced it has been named as an official supporter of the Terra Carta, HRH The Prince of Wales’ Sustainable Markets Initiative.

  • Zogenix Presents New Data at Virtual AAN 2021 Showing Improved Executive Function in Lennox-Gastaut Syndrome (LGS) Patients Treated with FINTEPLA® (Fenfluramine) Oral Solution

    LGS is one of the most challenging developmental and epileptic encephalopathies to manage because of high seizure frequency and significant neurodevelopmental impairment.More LGS study patients treated with FINTEPLA (fenfluramine) showed improvement in each of the BRIEF 2 indexes that have been used to assess behavior, emotion, and cognitive function in intractable epilepsy and other developmental conditions.Improvement was statistically significant for Cognition (27% vs 13% placebo, p=0.046) and the Global Executive Composite score (25% vs 11% placebo, p=0.034), where approximately twice as many patients achieved clinically meaningful improvement. EMERYVILLE, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZGNX), a global biopharmaceutical company developing rare disease therapies, today announced new data showing the positive impact of treatment with FINTEPLA® (fenfluramine) oral solution on everyday executive function for children and young adults with Lennox-Gastaut syndrome (LGS). FINTEPLA is being investigated for the treatment of seizures associated with LGS, a rare, severe epilepsy that is one of the most challenging developmental and epileptic encephalopathies to manage due to the high seizure frequency and significant neurodevelopmental impairment patients experience. The data, presented in an oral presentation and fireside chat at the virtual American Academy of Neurology (AAN) Annual Meeting this week, was the first presentation of FINTEPLA’s impact on LGS patients’ abilities to self-regulate behavior, emotions, and cognition. These new data complement earlier Phase 3 trial data demonstrating FINTEPLA’s ability to significantly reduce drop seizure frequency and, especially, generalized tonic-clonic seizure frequency (a primary risk factor for sudden unexpected death in epilepsy, or SUDEP) for many LGS patients. "FINTEPLA-treated children and young adults with LGS showed improved overall self-regulation, with specific improvements in regulation of attention and cognition after 14 weeks in a Phase 3 double-blind randomized controlled trial,” said Kim Bishop, Ph.D. of Global Pharma Consultancy and lead author for the study. “Better self-regulation can have a positive impact on children's everyday functioning and reduce caregiver burden.” AnalysisThe objective of this post-hoc analysis was to assess the impact of FINTEPLA (fenfluramine) on everyday executive function as captured using the Behavior Rating Inventory of Executive Function (BRIEF®) as part of the Zogenix 14-week randomized Phase 3 clinical trial of children and young adults with LGS. The BRIEF assessments were completed by caregivers or parents as part of the trial, which included a total of 263 LGS patients aged 2-35 years. After a 4-week baseline, patients were randomized to placebo or one of two fenfluramine doses. Treatment continued for a combined 14-week titration and maintenance period. Age-appropriate versions of the BRIEF were administered at baseline and end of study. This analysis included 137 patients (age 6-18) that had both baseline and end of-study BRIEF assessments (median age of 12 years), mapping the BRIEF ratings to the current BRIEF® 2 parent form, a shorter, 63-item version, which incorporates a large, 1,400-sample size normative population and statistics to support interpretation. This analysis did not include patients over 18 years of age because normative population data in adults is not yet available. The BRIEF 2 analysis utilizes the Reliable Change Index (RCI) for Behavior, Emotion, Cognition, and Global scores that represent a degree of confidence that the change represents a real effect (versus test-related errors and practice effects), and therefore is clinically meaningful. Associations between change in BRIEF 2 scores and combined active (0.2 and 0.7 mg/kg/day fenfluramine) versus placebo treatment groups were evaluated in cross tabulations using Somers’ D statistic. ResultsMean age of patients in the FINTEPLA (n=92) vs. placebo (n=45) groups was 12 ± 3.6, with 44% of the FINTEPLA patients being female vs. 53% in the placebo group. The frequency of clinically elevated T-scores at baseline, defined as a T-score ≥65, was substantial, suggesting frequent impairment in executive function, as would be expected for children with LGS. Subjects with greater improvement in seizure control were more likely to show clinically meaningful improvements in executive functioning after the 14-week study duration. More patients on FINTEPLA (fenfluramine) than placebo showed improvement in each of the four BRIEF 2 indexes (Behavior, Emotions, Cognition, and Global Executive Composite). Improvement was significantly greater for the CRI (Cognition) and GEC (Global Executive Composite) scores, indicating clinically meaningful improvement in the FINTEPLA (fenfluramine)-treated patients. Percentage of Patients Showing Clinically Meaningful Improvement (RCI ≥95% Certainty) in Active vs Placebo Treatment GroupsBRIEF® 2 IndexFINTEPLA®Fenfluramine (%) (N=92)Placebo (%)(N=45)P-ValueBRI (Behavior)24%13%0.118ERI (Emotions)19%16%0.665CRI (Cognition)27%13%0.046GEC (Global Executive Composite overarching summary score)25%11%0.034 “Analyses from our separate Phase 3 trials and long-term open label studies in Dravet syndrome, another difficult to treat rare epilepsy, showed that FINTEPLA provided sustained, clinically meaningful improvements in seizure control and executive function,” said Gail Farfel, Ph.D., Executive Vice President and Chief Development Officer at Zogenix and one of the study authors. “With a growing set of differentiating data in Lennox-Gastaut syndrome, we remain eager to continue advancing FINTEPLA as a potential new treatment option for patients living with this incredibly refractory disease.” Presentation Dr. Kim Bishop presented and discussed the data during Virtual AAN 2021; the slides from her presentation are archived on the Zogenix Newsroom. About Lennox-Gastaut SyndromeLennox-Gastaut Syndrome (LGS) is a rare and devastating lifelong childhood-onset epilepsy that can arise from multiple different causes. LGS is characterized by many different seizure types, including many that result in frequent falls and injuries and that often don't respond to currently available seizure medications The intellectual and behavioral problems associated with LGS, as well as around-the-clock care requirements, add to the complexity of life with this disease. About ZogenixZogenix is a global biopharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company’s first rare disease therapy, FINTEPLA® (fenfluramine) oral solution, has been approved by the U.S. FDA and the European Medicines Agency and is in development in Japan for the treatment of seizures associated with Dravet syndrome, a rare, severe lifelong epilepsy. The company has two additional late-stage development programs, one in a rare epilepsy called Lennox-Gastaut syndrome and one in a mitochondrial disease called TK2 deficiency. Zogenix plans to initiate a study of FINTEPLA in a genetic epilepsy called CDKL5 Deficiency Disorder (CDD) and is also collaborating with Tevard Biosciences to identify and develop potential next-generation gene therapies for Dravet syndrome and other genetic epilepsies. Forward-Looking StatementZogenix cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as “believes,” “anticipates,” “plans,” “expects,” “indicates,” “will,” “intends,” “potential,” “suggests,” “assuming,” “designed,” and similar expressions are intended to identify forward-looking statements. These statements are based on Zogenix’s current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by Zogenix that any of its plans will be achieved. Actual results may differ from those set forth in this release due to the risks and uncertainties inherent in patient outcomes and other risks described in Zogenix’s prior press releases as well as in public periodic filings with the U.S. Securities & Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Zogenix undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995. CONTACTS: ZogenixMelinda BakerSenior Director, Corporate Communications+1 (510) 788-8732 | corpcomms@zogenix.com InvestorsBrian Ritchie Managing Director, LifeSci Advisors LLC+1 (212) 915-2578 | britchie@lifesciadvisors.com MediaStefanie Tuck, Vice President, Porter Novelli+1 (978) 390-1394 | stefanie.tuck@porternovelli.com

  • Hearing Aids Market Size 2021 | Is Expected to Reach USD 11.02 Billion by 2028, Exhibiting a CAGR of 7.4 %

    Key Players Covered in the Hearing Aids Market are Sonova (Stafa, Switzerland), Demant A/S (Denmark), GN Store Nord A/S (Ballerup, Denmark), WS Audiology (Denmark), Starkey (Minnesota, U.S.), MED-EL (Medical Electronics) (Innsbruck, Austria), Cochlear Ltd (Sydney, Australia), RION Co., Ltd. (Tokyo, Japan) and Other Prominent Players.Pune, India, April 22, 2021 (GLOBE NEWSWIRE) -- The global “hearing aids market” size is expected to reach USD 11.02 billion by 2028, exhibiting a CAGR of 7.4 % during the forecast period. The increasing innovations in hearing technologies coupled with the trend for connected devices will have an incredible impact on the market growth during the forecast period, states Fortune Business Insights, in a report, titled “Hearing Aids Market, 2021-2028.” The market size stood at USD 6.47 billion in 2020 and USD 6.67 billion in 2021. Key Development: August 2020: GN Store Nord A/S introduced a breakthrough product called ReSound One. It involves a microphone in the ear canal. The new product utilizes microphone and receiving-in-ear design (M& RIE) to collect sounds and enhance user experience. The Report Lists the Key Players in this Market: Sonova (Stafa, Switzerland)Demant A/S (Denmark)GN Store Nord A/S (Ballerup, Denmark)WS Audiology (Denmark)Starkey (Minnesota, U.S.)MED-EL (Medical Electronics) (Innsbruck, Austria)Cochlear Ltd (Sydney, Australia)RION Co., Ltd. (Tokyo, Japan)Other prominent players Request a Sample Copy of the Global Hearing Aids Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hearing-aids-market-101573 Hearing Aids Highlights of the Report: Market Penetration: Comprehensive information on the product portfolios of the top players in the market.Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the marketCompetitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the marketMarket Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographiesMarket Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market Delayed Cochlear Implantations Procedures to Affect Business amid Coronavirus COVID-19 had a dramatic effect on the healthcare sector. The postponement of non-compulsory surgeries due to the surge in COVID-19 patients has resulted in a significant loss for the hearing aids industry. The demand for devices such as orthopedic implants, heart valves, intraocular lenses, and audiology diagnostics devices showcases the downward curve. Furthermore, the reduced sales and production of hearing aid instruments can considerably inhibit the market's growth. According to the British Irish Hearing Instrument Manufacturers Association, the sales of these aids decreased by 35.7% in 2020. Similarly, according to the Hearing Industries Association (HIA) statistics, unit sales of hearing devices in the U.S. declined by 18.0% in 2020. In addition, the deferment of cochlear implantations procedures has resulted in decreased sales, which, in turn, can retard the development of the global hearing aids market. To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/hearing-aids-market-101573 The Hearing Devices Segment to Dominate the Market Based on the product, the market is classified into hearing devices and hearing implants. The hearing devices segment can be further split into behind-the-ear (BTE), in the ear (ITE), receiver in the canal (RIC), completely in the canal (CIC), others (invisible in the canal). The hearing devices segment is expected to hold the largest share during the forecast period. The growth is attributed to the demand for BTE devices that resemble Bluetooth earphone devices Based on patient type, the market is classified into adults and pediatrics. The adults are likely to exhibit rapid growth during the forecast period. The development is attributed to the rising geriatric population and increasing awareness about various hearing devices & implants. Based on distribution channels, the market is classified into OTC, hospital pharmacies/ medical channels, and retail pharmacies/private practice. The hospital pharmacies segment is expected to account for the largest share during the forecast period. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Quick Buy - Hearing Aids Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101573 The report on the hearing aids market covers: Comprehensive assessment of the marketEsteemed ideas into the segmentsCutting-edge trends and significant drivers Main regions in the industryNotable developmentCOVID-19 impact Technological Advancement in Hearing Devices to Intensify Market The integration of intelligent technologies in hearing devices will boost the market growth in the forthcoming years. The emergence of digital platforms in devices will enhance the hearing experience for patients, which, in turn, will foster market growth. High-end features in devices such as high sound processing, compatibility with smartphones, Bluetooth connectivity, artificial intelligence (AI), rechargeable batteries, and tinnitus masking will spur opportunities for the market in the forthcoming years. Moreover, the introduction of innovative hearing devices by prominent will enable the market's speedy expansion in the upcoming years. For instance, in February 2020, Starkey introduced the launch of the next-generation Livio Edge AI. The device uses artificial intelligence to analyze the surrounding sounds and make immediate adjustments for a better user experience. It also has an aesthetic appeal to it because of the miniaturized device. Surging Geriatric Population to Foster Growth in Asia Pacific Asia Pacific is expected to increase rapidly during the forecast period due to the increasing demand for hearing implants. The surging geriatric population will foster growth of the market in the region. According to Hear-it.org, over 3.6 million Australians suffer from hearing loss, and the figure is projected to reach 7.8 million in 2060, which is expected to surge in the forthcoming years. The market in Europe is expected to hold the largest hearing aids market share during the forecast period. The growth in the region is attributed to strong government support. The increased research and development for advanced hearing devices will promote growth in the region. The presence of numerous companies such as GN Store Nord A/S, Senovo, Demant A/S, and WS Audiology will enhance the region's development. According to Hearing Link, about 12,000 people in the U.K. use cochlear implants. It would also propel growth. Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hearing-aids-market-101573 Table Of Contents : Introduction Research ScopeMarket SegmentationResearch MethodologyDefinitions and Assumptions Executive SummaryMarket Dynamics Market DriversMarket RestraintsMarket Opportunities Key Insights Prevalence of Hearing loss, By Key CountryTechnological Advancement Sin Hearing Aids MarketNew Product Launches Key Industry Developments (Mergers, Acquisitions, and Partnerships)Impact of COVID-19 Pandemic Global Hearing Aids Market Analysis, Insights and Forecast, 2017-2028 Key Findings / SummaryMarket Analysis, Insights and Forecast – By Product Hearing Devices BTE ( Behind the Ear)ITE (In the Ear)RIC (Receiver in the Canal)CIC (Completely in the Canal)Others (Invisible in the Canal, etc.) Hearing Implants Cochlear ImplantsBone Anchored Implants Market Analysis, Insights and Forecast – By Patient Type AdultsPediatrics Market Analysis, Insights and Forecast – By Distribution Channel OTC (Over the Counter)Medical Channel/ Hospitals PharmaciesPrivate Practice/ Retail Pharmacies Market Analysis, Insights and Forecast – By Region North AmericaEuropeAsia PacificRest of the World North America Hearing Aids Market Analysis, Insights and Forecast, 2017-2028 Key Findings / SummaryMarket Analysis – By Product Hearing Devices BTE ( Behind the Ear)ITE (In the Ear)RIC (Receiver in the Canal)CIC (Completely in the Canal)Others (Invisible in the Canal, etc.) Hearing Implants Cochlear ImplantsBone Anchored Implants Market Analysis – By Patient Type AdultsPediatrics Market Analysis – By Distribution Channel OTC (Over the Counter)Medical Channel/ Hospitals Pharmacies Private Practice/ Retail Pharmacies Market Analysis – By Country U.S.Canada Toc Continue… Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/hearing-aids-market-101573 SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION: Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline. Have a Look at Related Reports: Orthopedic Implants Market Share & Industry Analysis, By Product (Joint Reconstruction; Spinal Implants; Trauma Implants, Dental Implants; Orthobiologics, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026 Medical X-ray Market Size, Share & Covid-19 Impact Analysis, By Product Type (Static and Dynamic), By Technology Type (Analog and Digital), By Application (Dental, Veterinary, Cardiovascular Oncology, and Others), By End-User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2021-2028 North America Osteoporosis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Online Pharmacies) and Forecast, 2020-2027 Point of care Ultrasound Market Size, Share & COVID-19 Impact Analysis, By Product (Cart-based, and Hand-held), By End User (Hospitals, Clinics, and Others), and Regional Forecast, 2020-2026 Immunomodulators Market Size, Share & COVID-19 Impact Analysis, By Product Type (Immunosuppressant, Immunostimulants), By Application (Oncology, Respiratory, Multiple Sclerosis, and Others), and Regional Forecast, 2020-2027 About Us: Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. Contact Us: Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business Insights™LinkedIn | Twitter | Blogs Press Release: https://www.fortunebusinessinsights.com/press-release/hearing-aids-market-9313

  • Making sense of the OnePlus 9 Pro’s fascinating new camera system: What is 2x2 OCL? What’s so special about dual-native ISO? How is DOL-HDR different from regular HDR?

    If you’ve been paying attention to camera tech and smartphone cameras in general, some of the technical jargon – dual-native ISO, omni-directional AF, OCL sensors, 12-bit RAW, DOL-HDR – almost makes sense.

  • ATM Subsidiary, Sonoran Flower LLC., Secures 40,000 Square Foot Building for Expansion of Cultivation Facility

    TUCSON, AZ, April 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Anything Technologies Media, Inc. (OTC: EXMT), announced today that its subsidiary, Sonoran Flower LLC. has secured a second building outside of Phoenix Arizona for expanding its cultivation facility. With the additional indoor space, we are expected to increase our capacity for indoor craft flower by over 400%. This new 40,000 square foot facility has room for an indoor cultivation facility and kitchen for the production of a wide range of edibles. The company still has its 15,000 square foot facility outside of Tucson that will continue to operate. This news is in addition to the announcement that Sonoran Flower won the Arizona Dispensary License Lottery earlier this week. This license gives the company a dispensary, indoor grow, offsite grow, and kitchen for production of a wide range of edibles. “We are so pleased to locate and secure this new facility that is closer to the major Phoenix market. Our main focus will be on wholesale distribution state-wide to the 142 plus dispensaries in Arizona,” states Lee Katterman, President of Sonoran Flower. About Sonoran Flower LLC. https://sonoranflower.com/store Sonoran Flower was built on the belief that nature holds everything we need to heal. We are a multifaceted organization that cultivates, processes, and sells wholesale and retail hemp and Cannabis goods. We procure and produce top-quality hemp seeds, smokable hemp flower, hemp biomass, distillates, isolates and products such as vape, lotions, salves, and Hemp Beverage. To Buy Sonoran Flower CBD Products go to: https://sonoranflower.com/store or call 520-303-HEMP (4367) Please follow Sonoran Flower on Instagram @ https://www.instagram.com/azgrowbros/ Follow us on Twitter @ https://twitter.com/anythingtechmed Follow us on Instagram @ https://www.instagram.com/anythingcbdmeds/ And Facebook @ https://www.facebook.com/AnythingTechMed/ About Amethyst Beverage: https://www.amethystbeverage.com/ Amethyst Beverage, a Reno, NV based business, was established in October 2016 mostly as a directive to support a Philanthropy effort toward Cancer associated with Children and Adults. A portion of all sales will be contributed to several organizations nationally. Currently, Amethyst Beverage is the only water in the marketplace to carry Patented, USDA Organic, Vegan and Kosher certifications, and is also the only flavored (Strawberry/Watermelon, Orange/Mango, Pineapple/Coconut, Cran/Razz, Cucumber/Mint and Peach) alkaline water with fulvic acid containing 70 ionic minerals as well. About Anything Technologies Media, Inc. Anything Technologies Media is a manufacturing and marketing company involved in the sales and marketing of CBD Health products and software applications. ATM is the parent company of subsidiary Corporations and is focused on partnerships and acquisitions in new technologies and manufacturing sectors. The company and partners each have their own professional management team with extensive backgrounds in finance, manufacturing, marketing and distribution. ATM's goal is to combine the expertise of our team members to create a cohesive force, which will carry the company forward in the marketplace. Safe Harbor Statement Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release. Contact: Anything Technologies Media, Inc.acquisitions@anythingtechnologiesmedia.com

  • Wilson Electronics Announces Collaboration with 5G mmWave Leader ED2 Corporation

    Wilson Electronics, the industry leader in cellular signal amplifier technology, today announced a collaboration with ED2 Corporation.

  • An AI Service Dismantles Film Awards Through Crowd’s Choice

    For the 2021 People-Powered Film Awards, Maimovie selected 1,050 award categories that best reflect entertainment trends from AI-curated crowd data.